首頁
1
衛教資訊
2
藥物測試研究
3
NF國際醫療測試研究 - 44
http://www.nf.org.tw/custom_32019.html NF國際醫療測試研究 - 4 NF國際醫療測試研究 - 4 症狀 醫療測試方法  測試期別 Neurofibromatosis Type II  Drug: Everolimus (RAD001) , Afinitor®  Phase 2 Neurofibromatosis 2  Drug: PTC299 (VEGF)  Phase 2 Neurofibromatosis Type 1, Cutaneous Neurofibromas  Drug: Imiquimod 5% Cream   Neurofibromatosis Type 2, Vestibular Schwannomas  Drug: Axitinib  Phase 2 Acoustic Schwannoma, Neurofibromatosis Type 2 Biological: bevacizumab Phase 2 Other: laboratory biomarker analysis Procedure: quality-of-life assessment  Neurofibromatosis 2, Vestibular Schwannoma  Drug: Lapatinib  Phase 2 Plexiform Neurofibromas  Drug: Imatinib Mesylate  Phase 2 Neurofibromatosis Type 2, Neuroma, Acoustic  Drug: RAD001, everolimus  Phase 2 Low-grade Gliomas  Drug: Tarceva and Rapamycin  Phase 1 Neurofibromatosis  Drug: Gleevec  Phase 2 Brain and Central Nervous System Tumors Drug: carboplatin Phase 1 Neurofibromatosis Type 1  Drug: vinblastine sulfate  Neurofibromatosis Type 2 Drug: Bevacizumab  Phase 2 Progressive Vestibular Schwannomas  Neurofibromatoses Drug: Levulan (5-aminolevulinic acid) photodynamic therapy.  Phase 1 在本網頁提供的資料僅供參考,並非對醫療上的建議,也不構成上市臨床活動的認可。以上是美國和歐洲的資訊來源所整理的醫療試驗。 李銘仁整理 2015-12-07  

號外號外~恭喜!!優秀的病友學子們得到罕病協會的【優秀獎助學金】

首頁 衛教資訊 > 藥物測試研究 > NF國際醫療測試研究 - 4

症狀 醫療測試方法  測試期別
Neurofibromatosis Type II  Drug: Everolimus (RAD001) , Afinitor®  Phase 2
Neurofibromatosis 2  Drug: PTC299 (VEGF)  Phase 2
Neurofibromatosis Type 1, Cutaneous Neurofibromas  Drug: Imiquimod 5% Cream  
Neurofibromatosis Type 2, Vestibular Schwannomas  Drug: Axitinib  Phase 2
Acoustic Schwannoma, Neurofibromatosis Type 2 Biological: bevacizumab Phase 2
Other: laboratory biomarker analysis
Procedure: quality-of-life assessment 
Neurofibromatosis 2, Vestibular Schwannoma  Drug: Lapatinib  Phase 2
Plexiform Neurofibromas  Drug: Imatinib Mesylate  Phase 2
Neurofibromatosis Type 2, Neuroma, Acoustic  Drug: RAD001, everolimus  Phase 2
Low-grade Gliomas  Drug: Tarceva and Rapamycin  Phase 1
Neurofibromatosis  Drug: Gleevec  Phase 2
Brain and Central Nervous System Tumors Drug: carboplatin Phase 1
Neurofibromatosis Type 1  Drug: vinblastine sulfate 
Neurofibromatosis Type 2 Drug: Bevacizumab  Phase 2
Progressive Vestibular Schwannomas 
Neurofibromatoses Drug: Levulan (5-aminolevulinic acid) photodynamic therapy.  Phase 1

網頁提供的資料僅供參考,並非醫療上的建議,也不構成上市臨床活動的認可。以美國和歐洲的資訊來源所整理的醫療試驗

李銘仁整理 2015-12-07